%PDF-1.6
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2020-05-14T12:15:13+02:00
2020-05-14T12:15:16+02:00
2020-05-14T12:15:16+02:00
Adobe InDesign 15.0 (Macintosh)
uuid:2209bef2-ede2-5f41-a7b9-5edccc13a355
xmp.did:26925e19-527a-4c14-8496-3b8726b84d43
xmp.id:1c230615-c707-48e9-9470-3bf06d4ffabc
proof:pdf
xmp.iid:5f6ce43f-a3b5-4311-90e3-7470cb643095
xmp.did:87ec3004-736a-44a9-8cbf-db41e8698353
xmp.did:26925e19-527a-4c14-8496-3b8726b84d43
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 15.0 (Macintosh)
/
2020-05-14T12:15:13+02:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 78438>>/PageWidthList<0 1190.55>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/TrimBox[0.0 0.0 1190.55 668.976]/Type/Page>>
endobj
6 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 103685>>/PageWidthList<0 1190.55>>>>>>/Resources<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/TrimBox[0.0 0.0 1190.55 668.976]/Type/Page>>
endobj
7 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 105216>>/PageWidthList<0 1190.55>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 1190.55 668.976]/Type/Page>>
endobj
8 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 105224>>/PageWidthList<0 1190.55>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 1190.55 668.976]/Type/Page>>
endobj
9 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 105232>>/PageWidthList<0 1190.55>>>>>>/Resources<>>>/TrimBox[0.0 0.0 1190.55 668.976]/Type/Page>>
endobj
34 0 obj
<>stream
1 0.72 0 0.38 k
/GS0 gs
0 0 1190.552 668.976 re
f
q
0 0 1190.551 668.976 re
W n
0 0 0 0 k
q 1 0 0 1 660.8121 327.9331 cm
0 0 m
3.553 0 l
3.553 24.597 l
28.424 -1.442 l
28.424 31.921 l
24.869 31.921 l
24.869 7.196 l
0 33.276 l
h
-23.768 29.168 m
-16.453 29.168 -10.7 23.198 -10.7 15.962 c
-10.7 8.761 -16.539 2.751 -23.768 2.751 c
-31.002 2.751 -36.838 8.761 -36.838 15.962 c
-36.838 23.198 -31.089 29.168 -23.768 29.168 c
-23.768 32.474 m
-32.865 32.474 -40.393 25.064 -40.393 15.917 c
-40.393 6.732 -32.865 -0.549 -23.768 -0.549 c
-14.677 -0.549 -7.15 6.732 -7.15 15.917 c
-7.15 25.064 -14.677 32.474 -23.768 32.474 c
-47.374 31.921 -3.552 -31.921 re
-72.494 14.011 m
-71.607 14.011 l
-61.962 0 l
-57.606 0 l
-67.759 14.31 l
-62.852 14.734 -59.764 18.204 -59.764 23.117 c
-59.764 30.311 -65.389 31.921 -71.438 31.921 c
-76.047 31.921 l
-76.047 0 l
-72.494 0 l
h
-72.494 28.621 m
-71.438 28.621 l
-67.164 28.621 -63.317 28.112 -63.317 22.858 c
-63.317 17.908 -67.376 17.145 -71.395 17.145 c
-72.494 17.145 l
h
-103.286 3.3 m
-103.286 28.621 l
-100.707 28.621 l
-96.94 28.621 -93.726 28.112 -90.81 25.532 c
-88.06 23.117 -86.661 19.602 -86.661 15.962 c
-86.661 12.404 -88.017 9.059 -90.642 6.603 c
-93.559 3.852 -96.814 3.3 -100.707 3.3 c
h
-106.841 0 m
-100.918 0 l
-95.927 0 -92.122 0.635 -88.314 4.021 c
-84.803 7.155 -83.113 11.262 -83.113 15.917 c
-83.113 20.661 -84.76 24.937 -88.4 28.069 c
-92.164 31.289 -96.052 31.921 -100.831 31.921 c
-106.841 31.921 l
h
-131.541 0 m
-115 0 l
-115 3.3 l
-127.989 3.3 l
-127.989 15.834 l
-115.383 15.834 l
-115.383 19.134 l
-127.989 19.134 l
-127.989 28.621 l
-115 28.621 l
-115 31.921 l
-131.541 31.921 l
h
-155.945 18.246 m
-155.945 31.921 l
-159.497 31.921 l
-159.497 0 l
-155.945 0 l
-155.945 13.758 l
-155.057 14.649 l
-141.987 0 l
-137.081 0 l
-152.561 17.062 l
-137.588 31.921 l
-142.37 31.921 l
h
f
Q
q 1 0 0 1 685.8215 311.9746 cm
0 0 m
-4.054 0 l
-2.002 4.813 l
h
0.525 -1.245 m
1.937 -4.656 l
3.414 -4.656 l
-1.972 7.937 l
-7.501 -4.656 l
-6.041 -4.656 l
-4.592 -1.245 l
h
-33.747 -4.656 m
-32.376 -4.656 l
-30.837 3.475 l
-30.805 3.475 l
-26.96 -5.153 l
-23.095 3.475 l
-23.065 3.475 l
-21.522 -4.656 l
-20.155 -4.656 l
-22.586 8.048 l
-26.96 -2.042 l
-31.311 8.048 l
h
-52.389 0.62 m
-52.054 0.62 l
-48.433 -4.656 l
-46.794 -4.656 l
-50.609 0.733 l
-48.763 0.892 -47.602 2.199 -47.602 4.046 c
-47.602 6.757 -49.717 7.364 -51.993 7.364 c
-53.725 7.364 l
-53.725 -4.656 l
-52.389 -4.656 l
h
-52.389 6.121 m
-51.993 6.121 l
-50.385 6.121 -48.942 5.932 -48.942 3.953 c
-48.942 2.088 -50.463 1.8 -51.976 1.8 c
-52.389 1.8 l
h
-70.683 0 m
-74.736 0 l
-72.686 4.813 l
h
-70.159 -1.245 m
-68.744 -4.656 l
-67.263 -4.656 l
-72.653 7.937 l
-78.185 -4.656 l
-76.724 -4.656 l
-75.277 -1.245 l
h
-99.26 2.484 m
-99.26 7.364 l
-100.594 7.364 l
-100.594 -4.656 l
-99.26 -4.656 l
-99.26 1.241 l
-93.125 1.241 l
-93.125 -4.656 l
-91.791 -4.656 l
-91.791 7.364 l
-93.125 7.364 l
-93.125 2.484 l
h
-119.558 6.121 m
-119.069 6.121 l
-117.506 6.121 -115.937 5.976 -115.937 4.016 c
-115.937 2.295 -117.19 1.848 -118.67 1.848 c
-119.558 1.848 l
h
-119.558 0.605 m
-118.59 0.605 l
-117.586 0.605 -116.551 0.733 -115.743 1.402 c
-114.999 2.024 -114.599 3.011 -114.599 3.984 c
-114.599 5.052 -115.061 6.106 -115.952 6.727 c
-116.825 7.332 -117.889 7.364 -118.923 7.364 c
-120.894 7.364 l
-120.894 -4.656 l
-119.558 -4.656 l
h
-141.19 6.328 m
-138.44 6.328 -136.279 4.08 -136.279 1.356 c
-136.279 -1.356 -138.473 -3.621 -141.19 -3.621 c
-143.909 -3.621 -146.102 -1.356 -146.102 1.356 c
-146.102 4.08 -143.941 6.328 -141.19 6.328 c
-141.19 7.571 m
-144.609 7.571 -147.438 4.783 -147.438 1.334 c
-147.438 -2.123 -144.609 -4.863 -141.19 -4.863 c
-137.774 -4.863 -134.946 -2.123 -134.946 1.334 c
-134.946 4.783 -137.774 7.571 -141.19 7.571 c
-161.504 7.364 -1.336 -12.022 re
-182.802 6.121 m
-182.279 6.121 l
-180.64 6.121 -179.496 5.932 -179.496 4.11 c
-179.496 2.247 -180.784 2.072 -182.292 2.072 c
-182.802 2.072 l
h
-184.136 -4.656 m
-181.355 -4.656 l
-178.987 -4.656 -177.065 -3.699 -177.065 -1.309 c
-177.065 0.124 -177.908 1.417 -179.337 1.768 c
-178.528 2.309 -178.16 3.141 -178.16 4.11 c
-178.16 6.565 -179.988 7.364 -182.166 7.364 c
-184.136 7.364 l
h
-182.802 0.922 m
-181.641 0.922 l
-180.177 0.922 -178.4 0.651 -178.4 -1.215 c
-178.4 -3.046 -179.972 -3.414 -181.467 -3.414 c
-182.802 -3.414 l
h
f
Q
Q
endstream
endobj
11 0 obj
<>
endobj
30 0 obj
<>stream
q
0 0 1190.551 668.976 re
W n
1 0.83 0.32 0.14 K
2 w
/GS0 gs
q 1 0 0 1 648.2441 619.3696 cm
0 0 m
0 -634.251 l
S
Q
Q
BT
1 0.72 0 0.38 k
/GS0 gs
/TT0 1 Tf
-0.024 Tw 35 0 0 35 68.0315 242.7951 Tm
[(C)12 (OMMITMENT)24 ( T)30.1 (O )]TJ
-0.018 Tw 0 -1.057 Td
[(RESEARCH AND A)18 (C)6 (TION)]TJ
0 0 0 0.8 k
/TT1 1 Tf
-0.025 Tc 0 Tw 10 0 0 10 68.0315 172.8345 Tm
[(As we write K)30 (edrion is)-25 ( )]TJ
0 -1.5 Td
[(engaged on the fr)18 (ont line in)-25 ( )]TJ
/C2_0 1 Tf
0.025 Tw 0 -1.5 Td
[<0057004B004800030193004A004B005700030044004A0044004C00510056005700030026>12 <00520059004C004700100014001C0011>5.1 <0003>]TJ
/TT1 1 Tf
0 Tw 0 -1.5 Td
[(Our R&D Depar)12.1 (tment has)-25 ( )]TJ
0 -1.5 Td
[(focused its ef)18 (for)12 (ts on the use)-25 ( )]TJ
0 -1.5 Td
[(of)-24 ( \223)42 (convalescent plasma)24 (\224 \226 tha)10 (t)-24.9 ( )]TJ
0 -1.5 Td
[(is,)30 ( plasma dona)10 (ted by pa)10 (tients)-24.9 ( )]TJ
60.931 41.117 Td
[(an ef)18 (fective C)12 (ovid-19 tr)18 (e)6 (a)10 (tment.)5 ( )]TJ
0 -1.5 Td
[(K)12 (amada Ltd.)30 ( is an Isr)12 (aeli)-25 ( )]TJ
0 -1.5 Td
[(bio-tech company with which)-25 ( )]TJ
0 -1.5 Td
[(K)30 (edrion alr)18 (e)6 (ady collabor)12.1 (a)10 (tes)-25 ( )]TJ
0 -1.5 Td
[(on the )18 (Anti-R)12 (abies pr)18 (oduct)-25 ( )]TJ
0 -1.5 Td
[(KEDRAB\256.)30 ( Using convalescent)-25 ( )]TJ
0 -1.5 Td
[(plasma pr)18 (ovided by K)30 (edrion)-25 ( )]TJ
0 -1.5 Td
[(and a K)12 (amada pr)18 (oprietary)-25 ( )]TJ
0 -1.5 Td
[(IgG pla)10 (tform technology)36 (,)30 ( the)-25 ( )]TJ
0 -1.5 Td
[(te)6 (am will pr)18 (oduce a human)-25 ( )]TJ
-0.018 Tw 0 -1.5 Td
[(plasma-derived Anti-)12 (SARs-)]TJ
0 Tw 0 -1.5 Td
[(C)12 (O)12 (V)24 (-2 \(C)12 (ovid-19\) polyclonal)-25 ( )]TJ
0 -1.5 Td
[(Immunoglobulin \(IgG\) pr)18 (oduct)-25 ( )]TJ
0 -1.5 Td
[(as a potential tr)18 (e)6 (a)10 (tment for)-25 ( )]TJ
0 -1.5 Td
[(C)12 (or)18 (onavirus pa)10 (tients within a)-25 ( )]TJ
0 -1.5 Td
[(r)18 (ela)10 (tively shor)12 (t time \226 a hopeful)-25 ( )]TJ
0 -1.5 Td
[(and e)6.1 (x)6 (citing pr)18 (ospect.)5 ( )]TJ
0 -1.5 Td
[(T)18 (he primary focus of)-24 ( the)-25 ( )]TJ
0 -1.5 Td
[(collabor)12 (a)10 (tion initially will)-25 ( )]TJ
0 -1.5 Td
[(be to pr)18 (ovide the pr)18 (oduct)-25 ( )]TJ
0 -1.5 Td
[(as tr)18 (e)6 (a)10 (tment to pa)10 (tients)-25 ( )]TJ
0 -1.5 Td
[(in Italy)36 (,)30 ( Isr)12 (ael and the US)-25 ( )]TJ
/C2_0 1 Tf
-0.04 Tc 0.04 Tw -60.931 26.738 Td
[<0026005800550055>18 <00480051005700030047004C0049>18 <019300460058004F0057004C004800560003004B0044005900480003005100520057>-39.9 <0003>]TJ
0 -1.5 Td
[<00530055>18 <0048005900480051005700480047000300580056000300490055>18 <0052005000030055>18.1 <0048004600520051019300550050004C0051004A>-40 <0003>]TJ
/TT1 1 Tf
0 Tw 0 -1.5 Td
[(our solidarity with pa)10 (tient)-39.9 ( )]TJ
0 -1.5 Td
[(associa)10 (tions,)30 ( medical institutions,)-10 ( )]TJ
/C2_0 1 Tf
0.04 Tw 0 -1.5 Td
[<00560046004C004800510057004C019300460003005600520046004C00480057004C00480056000300440051004700030057004B00480003005A00520055004F0047>-40 <0003>]TJ
/TT1 1 Tf
0 Tw 0 -1.5 Td
[(of)-24 ( donors.)30.1 ( )11.9 (W)36.1 (e ar)18 (e r)18.1 (ecommit)12 (ted)-40 ( )]TJ
0 -1.5 Td
[(to maintaining the dialogue,)-10 ( )]TJ
0 -1.5 Td
[(e)6 (x)6 (change and trust built up over)-40 ( )]TJ
0 -1.5 Td
[(many ye)6 (ars of)-24 ( collabor)12 (a)10 (tion.)-10 ( )]TJ
0 -1.5 Td
[(W)36 (e have concentr)12 (a)10 (ted our focus)-40 ( )]TJ
15.236 13.5 Td
[(on pa)9.9 (tients and on guar)12 (anteeing)-40 ( )]TJ
0 -1.5 Td
[(them the supply of)-23.9 ( the medicines)-40 ( )]TJ
0 -1.5 Td
[(they need.)30 ( )24 (T)96 (o r)18 (educe the risk)-40 ( )]TJ
0 -1.5 Td
[(of)-24 ( e)6.1 (xposur)18 (e to C)12 (ovid-19,)30 ( we)-40 ( )]TJ
0 -1.5 Td
[(have suppor)12 (ted initia)10 (tives such)-40 ( )]TJ
0 -1.5 Td
[(as home delivery of)-23.9 ( medicines,)-10 ( )]TJ
0 -1.5 Td
[(especially ge)6.1 (ar)18 (ed towar)18 (ds)-40 ( )]TJ
0 -1.5 Td
[(safeguar)18 (ding those who)-40 ( )]TJ
0 -1.5 Td
[(ar)18 (e most vulner)12 (able.)]TJ
0 -1.5 Td
[(In Italy)36 (,)30 ( wher)18 (e we continue to)-40 ( )]TJ
-0.025 Tc 76.177 18.262 Td
[(of)-24 ( equipment and kits which we)-24.9 ( )]TJ
0 -1.5 Td
[(have supplied to the Na)10 (tional)-25 ( )]TJ
0 -1.5 Td
[(He)6 (alth S)12 (ystem.)5 ( )]TJ
0 -3 Td
[(T)18 (he Italian Society of)-23.9 ( )23.9 (T)90.1 (r)12 (ansfusion)-25 ( )]TJ
0 -1.5 Td
[(Medicine r)18 (ecommends)-25 ( )]TJ
0 -1.5 Td
[(tha)10 (t C)12 (ovid-19 convalescent)-25 ( )]TJ
0 -1.5 Td
[(plasma be vir)12 (ally inactiva)10 (ted)-25 ( )]TJ
/C2_0 1 Tf
0.025 Tw 0 -1.5 Td
[<004400510047000300530055>18 <00520046004800560056004800470003004C0051000300440003005400580044004F004C019300480047>-25 <0003>]TJ
/TT1 1 Tf
0 Tw 0 -1.5 Td
[(plant.)30 ( K)30 (edrion can sa)10 (tisfy these)-25 ( )]TJ
0 -1.5 Td
[(r)18 (equir)18.1 (ements a)10 (t our Sant)-24 (\222)48 (Antimo)-25 ( )]TJ
0 -1.5 Td
[(\(Italy\) plant wher)18 (e the C)12 (ovid-19)-25 ( )]TJ
0 -1.5 Td
[(convalescent plasma can)-24.9 ( )]TJ
0 -1.5 Td
[(under)18.1 (go solvent/deter)18 (gent)-25 ( )]TJ
0 -1.5 Td
[(\(S/D\) vir)12 (al inactiva)10 (tion tr)18 (e)6 (a)10 (tment.)]TJ
0 -3 Td
[(W)36 (e will continue to pr)18 (otect our)-24.9 ( )]TJ
0 -1.5 Td
[(employees,)30 ( serve our pa)10 (tients,)5 ( )]TJ
0 -1.5 Td
[(shar)18.1 (e with our communities)-25 ( )]TJ
0 -1.5 Td
[(and contribute to the local and)-24.9 ( )]TJ
0 -1.5 Td
[(global ef)18 (for)12 (ts to confr)18.1 (ont and)-25 ( )]TJ
0 -1.5 Td
[(defe)6 (a)10 (t the C)12 (ovid-19 pandemic.)]TJ
ET
q
0 0 1190.551 668.976 re
W n
1 0.83 0.32 0.14 K
2 w
q 1 0 0 1 42.937 187.0859 cm
0 0 m
0 494.404 l
S
Q
Q
BT
1 0.72 0 0.38 k
/TT0 1 Tf
-0.02 Tc 0.02 Tw 35 0 0 35 68.0315 516.2726 Tm
[(SUPPOR)12 (TING)-20 ( )]TJ
0 Tw 0 -1.057 Td
[(OUR C)12 (OMMUNITIES)-20 ( )]TJ
0 0 0 0.8 k
/TT1 1 Tf
-0.04 Tc 10 0 0 10 372.7154 446.3778 Tm
[(guar)12.1 (antee to the Na)10.1 (tional He)6 (alth)-40 ( )]TJ
0 -1.5 Td
[(S)12 (ystem contr)12 (act manufacturing)-40 ( )]TJ
0 -1.5 Td
[(services of)-24 ( plasma collected by)-40 ( )]TJ
0 -1.5 Td
[(the par)12 (tner R)12 (egions,)30 ( we work)-40 ( )]TJ
0 -1.5 Td
[(alongside donor associa)10 (tions in)-40 ( )]TJ
0 -1.5 Td
[(or)18 (der to r)12 (aise public awar)18 (eness)-40 ( )]TJ
0 -1.5 Td
[(on the need to dona)10 (te plasma,)-10 ( )]TJ
0 -1.5 Td
[(ther)18 (eby maintaining the supply)-40 ( )]TJ
0 -1.5 Td
[(of)-24 ( life-saving medicines.)-10 ( )]TJ
ET
q
0 0 1190.551 668.976 re
W n
q
0 Tc 0 g
/GS1 gs
0 TL/Fm0 Do
Q
q
0 Tc 0 g
/GS1 gs
0 TL/Fm1 Do
Q
Q
BT
-0.025 Tc 10 0 0 10 220.3937 172.8345 Tm
[(who have r)18 (ecover)18 (ed fr)18.1 (om the)-25 ( )]TJ
0 -1.5 Td
[(dise)6.1 (ase and is ther)18 (efor)18 (e lik)18 (ely)-24.9 ( )]TJ
0 -1.5 Td
[(rich in anti-virus antibodies.)30.1 ( )24 (T)18 (his)-25 ( )]TJ
0 -1.5 Td
[(plasma might be an ef)18 (fective)-25 ( )]TJ
0 -1.5 Td
[(tr)18 (e)6 (a)10 (tment when tr)12 (ansfused into)-25 ( )]TJ
0 -1.5 Td
[(pa)10 (tients suf)18 (fering fr)18 (om the virus.)5 ( )]TJ
-0.003 Tw 0 -1.5 Td
[(It can also be the sour)18.1 (ce of)-24 ( mor)18.1 (e)-25 ( )]TJ
0 Tw 15.236 9 Td
[(concentr)12 (a)10 (ted Immunoglobulin)-25 ( )]TJ
0 -1.5 Td
[(tha)10 (t might lik)18.1 (ewise pr)18 (ove to be)-25 ( )]TJ
0 -1.5 Td
[(an ef)18 (fective tr)18 (e)6 (a)10 (tment.)5 ( )]TJ
0 -3 Td
[(W)36 (e have just enter)18 (ed into an)-24.9 ( )]TJ
0 -1.5 Td
[(agr)18 (eement tha)10 (t could put us in a)-25 ( )]TJ
0 -1.5 Td
[(le)6 (ading position in the quest for)-25 ( )]TJ
45.694 41.102 Td
[(thr)18 (ough various clinical)-25 ( )]TJ
0 -1.5 Td
[(pr)18 (ogr)12.1 (ams,)30 ( and subsequently)-25 ( )]TJ
0 -1.5 Td
[(e)6 (xpanding development and)-25 ( )]TJ
0 -1.5 Td
[(commer)18.1 (cializa)10 (tion ef)18 (for)12 (ts to)-25 ( )]TJ
0 -1.5 Td
[(additional mark)17.9 (ets.)]TJ
0 -3 Td
[(W)36 (e have alr)18 (e)6 (ady begun to)-25 ( )]TJ
0 -1.5 Td
[(collect convalescent plasma)-25 ( )]TJ
0 -1.5 Td
[(in our KEDPLASMA)18 ( collection)-25 ( )]TJ
0 -1.5 Td
[(centers in the US and Hungary)36 (.)]TJ
0 -3 Td
[(T)18 (he use of)-24 ( convalescent)-25 ( )]TJ
0 -1.5 Td
[(plasma is alr)18 (e)6.1 (ady pr)18 (oducing)-25 ( )]TJ
0 -1.5 Td
[(pr)18 (omising r)18 (esults.)30 ( )12 (W)36 (e acted)-25 ( )]TJ
0 -1.5 Td
[(immedia)10 (tely by of)18 (fering our)-25 ( )]TJ
0 -1.5 Td
[(e)6 (xper)12 (tise and technology to)-25 ( )]TJ
0 -1.5 Td
[(tr)12 (ansfusion centers,)30 ( which in)-24.9 ( )]TJ
0 -1.5 Td
[(many R)12 (egions thr)18 (oughout Italy)-24.9 ( )]TJ
0 -1.5 Td
[(have adopted this ther)12 (apy)-25 ( )]TJ
0 -1.5 Td
[(on a trial basis.)30 ( In these cases)-25 ( )]TJ
0 -1.5 Td
[(the plasma under)18 (goes a vir)12 (al)-25 ( )]TJ
0 -1.5 Td
[(inactiva)10 (tion pr)18.1 (ocess with the use)-25 ( )]TJ
ET
endstream
endobj
31 0 obj
<>
endobj
32 0 obj
<>>>/Subtype/Form>>stream
0 0.51 1 0 k
/GS0 gs
609.449 -14.646 595.276 101.102 re
f
endstream
endobj
33 0 obj
<>>>/Subtype/Form>>stream
0 0.51 1 0 k
/GS0 gs
-14.173 575.433 572.598 107.716 re
f
endstream
endobj
36 0 obj
<>
endobj
35 0 obj
<>
endobj
21 0 obj
<>
endobj
12 0 obj
<>
endobj
13 0 obj
<>
endobj
41 0 obj
<>
endobj
42 0 obj
<>stream
H\͎@